Whitehawk Therapeutics (WHWK) Minority Interest (2015 - 2016)

Whitehawk Therapeutics (WHWK) reported Minority Interest of $73.8 million for Q4 2016, up 4.64% year-over-year from $70.5 million in Q1 2016, and up 4.64% quarter-over-quarter from $70.5 million in Q4 2015.

Whitehawk Therapeutics (WHWK) Minority Interest (2015 - 2016) Analysis & Trends

Whitehawk Therapeutics (WHWK) has 2 years of Minority Interest data on file, last reported at $73.8 million in Q4 2016.

  • Minority Interest for Q4 2016 came in at $73.8 million, up 4.64% year-over-year; the trailing twelve-month figure through Dec 2016 was $73.8 million (up 4.64% YoY), and the FY2016 annual result was $73.8 million, up 4.64% from the prior year.
  • Minority Interest climbed to $73.8 million in Q4 2016 per WHWK's latest filing, from $70.5 million in the prior quarter.
  • Over five years, Minority Interest peaked at $73.8 million in Q4 2016 and troughed at $70.5 million in Q4 2015.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn -
7 Psyence Biomedical 212.16 Bn 212.16 Bn -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn
9 Abivax 91.96 Bn 91.96 Bn -
10 Whitehawk Therapeutics 310.18 Mn 187.14 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2016 73.76 Mn
Dec 31, 2015 70.49 Mn